Breccia M, Salaroli A, Loglisci G, Finsinger P, Serrao A, Alimena G. MDS-specific comorbidity index is useful to identify myelodysplastic patients who can have better outcome with 5-azacitidine. Haematologica [Internet]. 2012Jan.31 [cited 2026Nov.4];97(2):e2-e2. Available from: https://haematologica.org/article/view/6226